Vicarious Surgical (RBOTW) Free Cash Flow (2020 - 2025)
Vicarious Surgical (RBOTW) reported Free Cash Flow of -$10.6 million for Q3 2025, up 16.41% year-over-year from -$9.1 million in Q3 2024, and up 21.81% on a QoQ basis from -$13.5 million in Q2 2025.
Vicarious Surgical (RBOTW) has 6 years of Free Cash Flow data on file, last reported at -$10.6 million in Q3 2025.
- Quarterly Free Cash Flow rose 16.41% year-over-year to -$10.6 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$35.9 million (up 28.42% YoY) and the FY2024 annual result came in at -$50.1 million, up 21.63% from the prior year.
- Free Cash Flow climbed to -$10.6 million in Q3 2025 per RBOTW's latest filing, from -$13.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$4.3 million in Q1 2021 and bottomed at -$19.4 million in Q4 2022.
- The 5-year median for Free Cash Flow is -$13.5 million (2025), against an average of -$13.2 million.
- The widest annual swing landed in 2021, when Free Cash Flow slumped 3845.99%; it then soared 36.04% in 2023.
- Tracing RBOTW's Free Cash Flow over 5 years: stood at -$10.6 million in 2021, then tumbled by 82.68% to -$19.4 million in 2022, then soared by 36.04% to -$12.4 million in 2023, then climbed by 3.43% to -$12.0 million in 2024, then grew by 11.7% to -$10.6 million in 2025.
- Per Business Quant, the three latest RBOTW Free Cash Flow figures stand at -$10.6 million (Q3 2025), -$13.5 million (Q2 2025), and -$11.8 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.58 Mn |
| Sep 30, 2025 | -10.58 Mn |
| Jun 30, 2025 | -13.53 Mn |
| Jun 30, 2025 | -13.53 Mn |
| Mar 31, 2025 | -11.77 Mn |
| Mar 31, 2025 | -11.77 Mn |
| Dec 31, 2024 | -11.98 Mn |
| Dec 31, 2024 | -11.98 Mn |
| Sep 30, 2024 | -12.66 Mn |
| Sep 30, 2024 | -12.66 Mn |
| Jun 30, 2024 | -11.03 Mn |
| Jun 30, 2024 | -11.03 Mn |
| Mar 31, 2024 | -14.47 Mn |
| Mar 31, 2024 | -14.47 Mn |
| Dec 31, 2023 | -12.41 Mn |
| Dec 31, 2023 | -12.41 Mn |
| Sep 30, 2023 | -17.40 Mn |
| Sep 30, 2023 | -17.40 Mn |
| Jun 30, 2023 | -15.29 Mn |
| Jun 30, 2023 | -15.29 Mn |
| Mar 31, 2023 | -18.88 Mn |
| Mar 31, 2023 | -18.88 Mn |
| Dec 31, 2022 | -19.40 Mn |
| Dec 31, 2022 | -19.40 Mn |
| Sep 30, 2022 | -14.62 Mn |
| Sep 30, 2022 | -14.62 Mn |
| Jun 30, 2022 | -15.76 Mn |
| Jun 30, 2022 | -15.76 Mn |
| Mar 31, 2022 | -16.79 Mn |
| Mar 31, 2022 | -16.79 Mn |
| Dec 31, 2021 | -10.62 Mn |
| Dec 31, 2021 | -10.62 Mn |
| Sep 30, 2021 | -13.72 Mn |
| Sep 30, 2021 | -13.72 Mn |
| Jun 30, 2021 | -5.98 Mn |
| Jun 30, 2021 | -5.98 Mn |
| Mar 31, 2021 | -4.27 Mn |
| Mar 31, 2021 | -4.27 Mn |
| Dec 31, 2020 | -482,301.00 |
| Dec 31, 2020 | -482,301.00 |
| Sep 30, 2020 | -347,771.00 |
| Sep 30, 2020 | -347,771.00 |